Evidence map›Paper›PMID 22422617›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2012

Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells.

Hesham M El-Shewy, Mimi Sohn, Parker Wilson, Mi Hye Lee, Samar M Hammad, Louis M Luttrell, Ayad A Jaffa

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Mitigation of Ferroptosis in Diabetic Kidney Disease Through Mesenchymal Stem Cell Intervention via the Smad2/3/METTL3/S1PR1 Axis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Hesham M El-ShewyDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Mimi Sohn
Parker Wilson
Mi Hye Lee
Samar M Hammad
Louis M Luttrell
Ayad A Jaffa
Medical University of South Carolina · USAmerican University of Beirut · LB

Funding

THE ROLE OF LACTOSYLCERAMIDE IN RENAL AGING AND DISEASEP20RR017677 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HSU, YI-TE · 2002 to 2011
$23.4M
TYROSINE KINASES IN G PROTEIN MEDIATED SIGNALINGR01DK055524 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LUTTRELL, LOUIS M · 1998 to 2017
$4.6M
MECHANISMS OF VASCULAR DISEASE IN DIABETESR01HL077192 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JAFFA, AYAD A · 2006 to 2017
$3.4M
KALLIKREIN AND VASCULAR DISEASE RISK IN DIABETESR01HL087986 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JAFFA, AYAD A · 2008 to 2011
$1.3M
Tyrosine Kinases in G Protein Mediated SignalingR56DK055524 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LUTTRELL, LOUIS M · 2008 to 2008
$284k
Mechanisms of Diabetic Renal Damage: Role of the Kinin ReceptorsF30DK083208 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WILSON, PARKER C. · 2011 to 2012
$82k
NCRR NIH HHS P20 RR017677NCRR NIH HHS P2 RR17677NHLBI NIH HHS HL077192NHLBI NIH HHS HL087986NHLBI NIH HHS R01 HL077192NHLBI NIH HHS R01 HL087986NIDDK NIH HHS DK55524NIDDK NIH HHS F30 DK083208NIDDK NIH HHS R01 DK055524NIDDK NIH HHS R56 DK055524
6 · The paper itself

Abstract

The pro-fibrotic connective tissue growth factor (CTGF) has been linked to the development and progression of diabetic vascular and renal disease. We recently reported that low-density lipoproteins (LDL) induced expression of CTGF in aortic endothelial cells. However, the molecular mechanisms are not fully defined. Here, we have studied the mechanism by which LDL regulates CTGF expression in renal mesangial cells. In these cells, treatment with pertussis toxin abolished LDL-stimulated activation of ERK1/2 and c-Jun N-terminal kinase (JNK), indicating the involvement of heterotrimeric G proteins in LDL signaling. Treatment with LDL promoted activation and translocation of endogenous sphingosine kinase 1 (SK1) from the cytosol to the plasma membrane concomitant with production of sphingosine-1-phosphate (S1P). Pretreating cells with SK inhibitor, dimethylsphinogsine or down-regulation of SK1 and SK2 revealed that LDL-dependent activation of ERK1/2 and JNK is mediated by SK1. Using a green fluorescent protein-tagged S1P₁ receptor as a biological sensor for the generation of physiologically relevant S1P levels, we found that LDL induced S1P receptor activation. Pretreating cells with S1P₁/S1P₃ receptor antagonist VPC23019 significantly inhibited activation of ERK1/2 and JNK by LDL, suggesting that LDL elicits G protein-dependent activation of ERK1/2 and JNK by stimulating SK1-dependent transactivation of S1P receptors. Furthermore, S1P stimulation induced expression of CTGF in a dose-dependent manner that was markedly inhibited by blocking the ERK1/2 and JNK signaling pathways. LDL-induced CTGF expression was pertussis toxin sensitive and inhibited by dimethylsphinogsine down-regulation of SK1 and VPC23019 treatment. Our data suggest that SK1-dependent S1P receptor transactivation is upstream of ERK1/2 and JNK and that all three steps are required for LDL-regulated expression of CTGF in mesangial cells.

Indexed as

Transcriptional ActivationUp-RegulationAnimalsCell MembraneCells, CulturedConnective Tissue Growth FactorDiabetic NephropathiesDyslipidemiasGene SilencingHumansLipoproteins, LDLLysophospholipidsMAP Kinase Signaling SystemMesangial CellsPhosphotransferases (Alcohol Group Acceptor)Protein IsoformsConnective Tissue Growth FactorLipoproteins, LDLLysophospholipidsPhosphotransferases (Alcohol Group Acceptor)Protein IsoformsReceptors, LysosphingolipidRecombinant Fusion ProteinsRNA, MessengerRNA, Small InterferingS1PR1 protein, humanSphingosinesphingosine 1-phosphateSphingosine-1-Phosphate ReceptorsSphingosine Kinase

Identifiers

PMID22422617
PMCPMC3355554
OpenAlexW2063606517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.